These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26556413)

  • 21. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.
    Mortier S; De Vriese AS; Lameire N
    Blood Purif; 2003; 21(1):14-23. PubMed ID: 12566656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.
    Witowski J; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Jörres A; Lage C; Schaub TP; Passlick-Deetjen J; Breborowicz A; Grzegorzewska A; Ksiazek A; Liberek T; Lichodziejewska-Niemierko M; Majdan M; Rutkowski B; Stompór T; Sulowicz W
    Nephrol Dial Transplant; 2004 Apr; 19(4):917-24. PubMed ID: 15031350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
    Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
    Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport.
    Del Peso G; Jiménez-Heffernan JA; Bajo MA; Aroeira LS; Aguilera A; Fernández-Perpén A; Cirugeda A; Castro MJ; de Gracia R; Sánchez-Villanueva R; Sánchez-Tomero JA; López-Cabrera M; Selgas R
    Kidney Int Suppl; 2008 Apr; (108):S26-33. PubMed ID: 18379544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biocompatibility of peritoneal dialysis fluids].
    Boulanger E; Moranne O; Wautier MP; Rougier JP; Ronco P; Pagniez D; Wautier JL
    Nephrol Ther; 2005 Mar; 1(1):14-22. PubMed ID: 16895663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studying the effects of new peritoneal dialysis solutions on the peritoneum.
    Chan TM; Yung S
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S87-93. PubMed ID: 17556337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatibility studies with bicarbonate-based solutions.
    Pedersen FB
    Adv Perit Dial; 1994; 10():245-50. PubMed ID: 7999838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneal aging during PD: implication of RAGE, the receptor for AGEs.
    Boulanger E; Daroux M
    Nefrologia; 2008; 28 Suppl 6():5-10. PubMed ID: 18957005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis.
    Selgas R; Bajo A; Jiménez-Heffernan JA; Sánchez-Tomero JA; Del Peso G; Aguilera A; López-Cabrera M
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii2-7. PubMed ID: 16825254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.
    Rippe B; Simonsen O; Heimbürger O; Christensson A; Haraldsson B; Stelin G; Weiss L; Nielsen FD; Bro S; Friedberg M; Wieslander A
    Kidney Int; 2001 Jan; 59(1):348-57. PubMed ID: 11135090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis and treatment of peritoneal membrane failure.
    Saxena R
    Pediatr Nephrol; 2008 May; 23(5):695-703. PubMed ID: 17891546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.
    Hirahara I; Ishibashi Y; Kaname S; Kusano E; Fujita T
    Nephrol Dial Transplant; 2009 Feb; 24(2):437-47. PubMed ID: 18790810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal dialysis solutions low in glucose degradation products--evidence for clinical benefits.
    Tomo T
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S123-7. PubMed ID: 18552241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?
    Farhat K; van Ittersum FJ; Ter Wee PM; Douma CE
    NDT Plus; 2008 Oct; 1(Suppl 4):iv46-iv50. PubMed ID: 25983986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic cells: mesothelial cells -- central players in regulating inflammation and resolution.
    Yung S; Chan TM
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S21-7. PubMed ID: 19270220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
    Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
    J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose degradation products and the peritoneal mesothelium.
    Jörres A; Bender TO; Witowski J
    Perit Dial Int; 2000; 20 Suppl 5():S19-22. PubMed ID: 11229607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissolved molecular hydrogen (H
    Nakayama M; Zhu WJ; Watanabe K; Gibo A; Sherif AM; Kabayama S; Ito S
    BMC Nephrol; 2017 Oct; 18(1):327. PubMed ID: 29089029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
    Park MS
    Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.